DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹103,419.3 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| MANKIND PHARMA | ₹91,572.1 Cr | -3.3% | -6.3% | -6.7% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.5% |
3.1% |
0.4% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses